Experience with leflunomide as treatment and as secondary prophylaxis for cytomegalovirus infection in lung transplant recipients: A case series and review of the literature.

Jose Tiago SilvaVirginia Pérez-GonzálezFrancisco López-MedranoRodrigo Alonso-MoralejoMario Fernández-RuizRafael San-JuanPatricia BrañasMaría Dolores FolgueiraJosé María AguadoAlicia de Pablo-Gafas

Published in: Clinical transplantation (2017)

Leflunomide, alone or in combination, could be an effective treatment in selected LT recipients with GCV-resistant CMV infection and as secondary prophylaxis. Further studies are necessary.

Keyphrases

combination therapy
replacement therapy
kidney transplantation
smoking cessation
case control